Amp Capital Investors LTD Has Trimmed Position in Leidos Hldgs (LDOS) as Market Valuation Declined; First Financial Cut Its Stake in Johnson & Johnson (JNJ) by $310,804 as Shares Declined

May 21, 2018 - By Marguerite Chambers

Johnson & Johnson (NYSE:JNJ) Logo

Amp Capital Investors Ltd decreased its stake in Leidos Hldgs Inc (LDOS) by 3.26% based on its latest 2017Q4 regulatory filing with the SEC. Amp Capital Investors Ltd sold 4,712 shares as the company’s stock declined 1.10% with the market. The institutional investor held 139,745 shares of the technology company at the end of 2017Q4, valued at $9.02M, down from 144,457 at the end of the previous reported quarter. Amp Capital Investors Ltd who had been investing in Leidos Hldgs Inc for a number of months, seems to be less bullish one the $9.32 billion market cap company. The stock increased 0.15% or $0.09 during the last trading session, reaching $61.4. About 609,872 shares traded. Leidos Holdings, Inc. (NYSE:LDOS) has risen 24.71% since May 21, 2017 and is uptrending. It has outperformed by 13.16% the S&P500.

First Financial Corp decreased its stake in Johnson & Johnson (JNJ) by 26.63% based on its latest 2017Q4 regulatory filing with the SEC. First Financial Corp sold 2,236 shares as the company’s stock declined 9.21% with the market. The institutional investor held 6,162 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $860,000, down from 8,398 at the end of the previous reported quarter. First Financial Corp who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $331.84B market cap company. The stock decreased 0.42% or $0.52 during the last trading session, reaching $123.72. About 5.52 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since May 21, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

Investors sentiment increased to 0.87 in Q4 2017. Its up 0.04, from 0.83 in 2017Q3. It increased, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. Amer Bank holds 2.32% or 58,898 shares. Sandhill Prtnrs Limited Liability holds 0.21% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 8,415 shares. Regis Mngmt Llc holds 0.07% or 3,213 shares in its portfolio. Nelson Van Denburg Campbell Wealth Mgmt Ltd Com accumulated 19,047 shares. Rockefeller Services reported 0.37% in Johnson & Johnson (NYSE:JNJ). Northside Cap Management Lc owns 12,527 shares for 0.5% of their portfolio. 8,600 were accumulated by Community Retail Bank Of Raymore. Endurant Capital Mngmt LP owns 2.6% invested in Johnson & Johnson (NYSE:JNJ) for 60,800 shares. Payden & Rygel invested in 0.12% or 10,200 shares. Tiedemann Wealth Mgmt Ltd Llc holds 0.43% or 39,958 shares. Fcg Advsr, New Jersey-based fund reported 38,104 shares. First Wilshire Mgmt reported 1,696 shares stake. Northstar Asset Mgmt has invested 2.12% in Johnson & Johnson (NYSE:JNJ). Mcrae Cap Mgmt Inc, New Jersey-based fund reported 27,240 shares. Covington Invest Advsrs Inc, Pennsylvania-based fund reported 28,413 shares.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 100 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, March 23 by Jefferies. On Tuesday, August 15 the stock rating was maintained by Jefferies with “Hold”. The company was maintained on Tuesday, August 25 by Cowen & Co. As per Wednesday, October 18, the company rating was maintained by Wells Fargo. As per Thursday, August 31, the company rating was maintained by BMO Capital Markets. The firm earned “Hold” rating on Thursday, August 4 by Jefferies. The firm has “Buy” rating by UBS given on Wednesday, October 19. On Thursday, July 14 the stock rating was maintained by Jefferies with “Hold”. Piper Jaffray reinitiated Johnson & Johnson (NYSE:JNJ) rating on Monday, October 5. Piper Jaffray has “Neutral” rating and $105.0 target. The firm has “Hold” rating given on Wednesday, April 18 by Stifel Nicolaus.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 17. They expect $2.05 earnings per share, up 12.02% or $0.22 from last year’s $1.83 per share. JNJ’s profit will be $5.50 billion for 15.09 P/E if the $2.05 EPS becomes a reality. After $2.06 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -0.49% negative EPS growth.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Johnson & Johnson Sells Off After Earnings” on April 22, 2018, also Seekingalpha.com with their article: “Johnson & Johnson (JNJ) Consumer and Medical Devices Business Review – Brokers Conference Transcript” published on May 17, 2018, Livetradingnews.com published: “Johnson & Johnson (NYSE:JNJ) Stock Oversold” on May 03, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Fool.com and their article: “Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV)” published on May 02, 2018 as well as Investorplace.com‘s news article titled: “7 ‘Blue-Chip Stocks’ That Aren’t Blue Chips at All” with publication date: May 21, 2018.

Since February 15, 2018, it had 0 buys, and 1 sale for $20.17 million activity.

Amp Capital Investors Ltd, which manages about $18.64 billion US Long portfolio, upped its stake in Price T Rowe Group Inc (NASDAQ:TROW) by 20,393 shares to 90,893 shares, valued at $9.54M in 2017Q4, according to the filing. It also increased its holding in International Business Machs (NYSE:IBM) by 28,131 shares in the quarter, for a total of 494,439 shares, and has risen its stake in National Retail Pptys Inc (NYSE:NNN).

Investors sentiment increased to 1.25 in 2017 Q4. Its up 0.10, from 1.15 in 2017Q3. It improved, as 24 investors sold LDOS shares while 114 reduced holdings. 67 funds opened positions while 106 raised stakes. 105.99 million shares or 1.23% less from 107.32 million shares in 2017Q3 were reported. 13,997 were reported by Brinker Capital. Swiss Bancorporation reported 528,200 shares. Commerzbank Aktiengesellschaft Fi accumulated 15,665 shares or 0.01% of the stock. Retail Bank Of Montreal Can holds 37,918 shares or 0% of its portfolio. Symphony Asset Management Ltd Com accumulated 10,344 shares or 0.07% of the stock. Goldman Sachs Grp Inc, New York-based fund reported 2.83M shares. Thompson Siegel Walmsley Ltd Company reported 0% in Leidos Holdings, Inc. (NYSE:LDOS). Alyeska Group Inc Ltd Partnership holds 0.02% of its portfolio in Leidos Holdings, Inc. (NYSE:LDOS) for 37,912 shares. Ameriprise Incorporated stated it has 0.05% of its portfolio in Leidos Holdings, Inc. (NYSE:LDOS). Suntrust Banks invested 0.01% in Leidos Holdings, Inc. (NYSE:LDOS). Aqr Management Lc has invested 0.03% of its portfolio in Leidos Holdings, Inc. (NYSE:LDOS). Washington Capital Mngmt stated it has 0.49% of its portfolio in Leidos Holdings, Inc. (NYSE:LDOS). 55 are owned by Earnest Partners Llc. Vanguard Grp Incorporated invested 0.04% of its portfolio in Leidos Holdings, Inc. (NYSE:LDOS). 706 are held by Whittier Tru.

Analysts await Leidos Holdings, Inc. (NYSE:LDOS) to report earnings on August, 2. They expect $1.07 earnings per share, up 2.88% or $0.03 from last year’s $1.04 per share. LDOS’s profit will be $162.42M for 14.35 P/E if the $1.07 EPS becomes a reality. After $1.03 actual earnings per share reported by Leidos Holdings, Inc. for the previous quarter, Wall Street now forecasts 3.88% EPS growth.

Leidos Holdings, Inc. (NYSE:LDOS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts